1. Home
  2. PHGE vs OMH Comparison

PHGE vs OMH Comparison

Compare PHGE & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • OMH
  • Stock Information
  • Founded
  • PHGE 2015
  • OMH 2015
  • Country
  • PHGE Israel
  • OMH Singapore
  • Employees
  • PHGE N/A
  • OMH N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • PHGE Health Care
  • OMH Finance
  • Exchange
  • PHGE Nasdaq
  • OMH Nasdaq
  • Market Cap
  • PHGE 11.1M
  • OMH 9.2M
  • IPO Year
  • PHGE N/A
  • OMH 2023
  • Fundamental
  • Price
  • PHGE $0.62
  • OMH $0.39
  • Analyst Decision
  • PHGE Strong Buy
  • OMH Strong Buy
  • Analyst Count
  • PHGE 2
  • OMH 1
  • Target Price
  • PHGE $22.50
  • OMH $1.50
  • AVG Volume (30 Days)
  • PHGE 72.5K
  • OMH 184.0K
  • Earning Date
  • PHGE 11-14-2024
  • OMH 01-03-2025
  • Dividend Yield
  • PHGE N/A
  • OMH N/A
  • EPS Growth
  • PHGE N/A
  • OMH N/A
  • EPS
  • PHGE N/A
  • OMH N/A
  • Revenue
  • PHGE N/A
  • OMH $5,390,607.00
  • Revenue This Year
  • PHGE N/A
  • OMH $101.90
  • Revenue Next Year
  • PHGE N/A
  • OMH $38.34
  • P/E Ratio
  • PHGE N/A
  • OMH N/A
  • Revenue Growth
  • PHGE N/A
  • OMH 25.77
  • 52 Week Low
  • PHGE $0.48
  • OMH $0.32
  • 52 Week High
  • PHGE $8.55
  • OMH $6.00
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 45.57
  • OMH 46.49
  • Support Level
  • PHGE $0.56
  • OMH $0.37
  • Resistance Level
  • PHGE $0.69
  • OMH $0.41
  • Average True Range (ATR)
  • PHGE 0.08
  • OMH 0.03
  • MACD
  • PHGE 0.01
  • OMH -0.00
  • Stochastic Oscillator
  • PHGE 28.57
  • OMH 12.90

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.

Share on Social Networks: